Salama et al. described how miR-223 regulates inflammation in IBD by controlling the TNFα/NFκB/NLRP3 inflammatory axis by exerting a counter-regulatory effect on NLRP3 expression. This evidence concerns the gene NLRP3 and irritable bowel syndrome.